Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain Stimulation
A. Etiévant,
C. Oosterhof,
C. Bétry,
E. Abrial,
M. Novo-Perez,
R. Rovera,
H. Scarna,
C. Devader,
J. Mazella,
G. Wegener,
C. Sánchez,
O. Dkhissi-Benyahya,
C. Gronfier,
V. Coizet,
J.M. Beaulieu,
P. Blier,
G. Lucas,
N. Haddjeri
Affiliations
A. Etiévant
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
C. Oosterhof
Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada
C. Bétry
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
E. Abrial
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
M. Novo-Perez
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
R. Rovera
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
H. Scarna
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
C. Devader
Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, UMR6097, Université de Nice Sophia Antipolis, 06560 Valbonne, France
J. Mazella
Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, UMR6097, Université de Nice Sophia Antipolis, 06560 Valbonne, France
G. Wegener
Department of Clinical Medicine, Translational Neuropsychiatry Unit, Aarhus University, Skovagervej 2, DK-8240 Risskov, Denmark
C. Sánchez
Neuropharmacology, Lundbeck Research USA, Paramus, NJ, USA
O. Dkhissi-Benyahya
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
C. Gronfier
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
V. Coizet
INSERM U836, GIN, Univ. Grenoble Alpes, F-38000 Grenoble, France
J.M. Beaulieu
Department of Psychiatry and Neurosciences, Faculty of Medicine, Laval University–IUSMQ, Québec City, Québec, Canada
P. Blier
Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada
G. Lucas
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
N. Haddjeri
Stem Cell and Brain Research Institute, INSERM U846, 69500 Bron, France
Although deep brain stimulation (DBS) shows promising efficacy as a therapy for intractable depression, the neurobiological bases underlying its therapeutic action remain largely unknown. The present study was aimed at characterizing the effects of infralimbic prefrontal cortex (IL-PFC) DBS on several pre-clinical markers of the antidepressant-like response and at investigating putative non-neuronal mechanism underlying DBS action. We found that DBS induced an antidepressant-like response that was prevented by IL-PFC neuronal lesion and by adenosine A1 receptor antagonists including caffeine. Moreover, high frequency DBS induced a rapid increase of hippocampal mitosis and reversed the effects of stress on hippocampal synaptic metaplasticity. In addition, DBS increased spontaneous IL-PFC low-frequency oscillations and both raphe 5-HT firing activity and synaptogenesis. Unambiguously, a local glial lesion counteracted all these neurobiological effects of DBS. Further in vivo electrophysiological results revealed that this astrocytic modulation of DBS involved adenosine A1 receptors and K+ buffering system. Finally, a glial lesion within the site of stimulation failed to counteract the beneficial effects of low frequency (30 Hz) DBS. It is proposed that an unaltered neuronal–glial system constitutes a major prerequisite to optimize antidepressant DBS efficacy. It is also suggested that decreasing frequency could heighten antidepressant response of partial responders.